U.S. life sciences companies secured $1.9 billion in venture capital financing in the fourth quarter, according to a new report from online venture capital database VentureDeal.
The $1.9 billion represents almost no change compared with the third quarter and continues a stable trend of financing for companies in the biotechnology, pharmaceutical and medical-devices fields.
Biotechnology received the most money — $871 million among 69 companies. Medical devices followed, with 78 companies raising $572 million during the quarter. Forty-five pharmaceutical companies raised $460 million.
To read the full, original article click on this link: Reports about venture capital investments in life sciences companies are mixed - Kansas City Business Journal:
Author: Tom Thornton
